NeoGenomics (NEO) Reports In-Line Q3 EPS

NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $22.43 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
• Vista Outdoor (VSTO) CSG Sends Letter to Senator J.D. Vance Addressing His Concerns Regarding Planned Acquisition of Vista Outdoor’s Sporting Products Business (VSTO)
• Boot Barn (BOOT) PT Raised to $110 at Piper Sandler